Table 6 Stated indications for administration of maropitant in dogs with no history of GI signs on presentation.

From: Prospective observational study of the use of omeprazole and maropitant citrate in veterinary specialist care

Indication

Ward

Medicine (N = 21)

N (%)

Surgery (N = 19)

N (%)

Vomiting while hospitalised

3 (14.3)

3 (15.8)

Regurgitation while hospitalised

1 (4.8)

5 (26.3)

Diarrhoea while hospitalised

0

0

Decreased appetite while hospitalised

10 (47.6)

2 (10.5)

Signs of nausea while hospitalised

9 (42.9)

6 (31.6)

Signs of GI haemorrhage or ulceration

0

0

Concurrent disease

4 (19.0)

11 (57.9)

Concurrent medications

0

0

Prophylactic treatment to decrease risk of gastro-oesophageal reflux under GA

0

7 (36.8), all for dogs with BOAS

  1. GA: general anaesthesia, BOAS: brachycephalic airway obstructive syndrome. Note that numbers summate to more than the number of questionnaire responses because some questionnaires contained multiple domains.
Back to article page